In small‐cell lung cancer, galectin‐9 expression in tumor‐infiltrating lymphocytes positively correlated with PD1, CD3, CD8, and FOXP3.[46] Overall, these studies indicate that galectin‐9 plays a comprehensive role in supporting the immunosuppressive tumor microenvironment. This evidence concerns the gene PDCD1 and neoplasm.